CRYPTOCOCCUS NEOFORMANS LATEX AGGLUTINATION SYSTEMS

 

The Latex-Cryto Antigen Detection System is a simple and rapid latex agglutination test for the qualitative and semi-quantitative detection of the capsular polysaccharide antigens of Cryptococcus neoformans in serum and cerbrospinal fluid (CSF). Cryptococcal antigen is frequently present in the serum of patients with pulmonary cryptococcosis and in the CSF and serum of patients with central nervous system involvement.

Currently, almost 50% of all cryptococcosis cases occur in HIV positive individuals. Other than AIDS patients, cryptococcosis occurs in normal individuals (rarely) and in subjects with impaired immune systems due to: 1) undelying diseases such as lupus erythematosis, sarcoidosis, leukemia, lymphoma and Cushman's Disease; 2) immuno suppressive therapies such as corticostreroids, cytotoxic drugs and transplantation therapies.

Since its introduction by IMMY in 1982, Detacher Enzyme (DE), Pronase®, has proven to be a vital component. DE digests antibodies in immune complexes (the antigen is not affected), which can mask the detection of antigens. DE also eliminates rheumatoid factor, which can cause false positives.

"Pronase" is a registered trademark of CALBIOCHEM Corporation.

 

Cryptococcus Latex Agglutination Systems

PRODUCT NUMBER DESCRIPTION PACKAGING
CR1003 LATEX-CRYPTO ANTIGEN SYSTEM Up to 50 Screening Tests
CR1004 LATEX-CRYPTO ANTIGEN SYSTEM Up to 120 Screening Tests
CR1005 LATEX-CRYPTO ANTIGEN SYSTEM Up to 240 Screening Tests

 

Cryptococcus Latex Agglutination Reagents

PRODUCT NUMBER DESCRIPTION PACKAGING
CB0010 Low-Cryptococcal Antigen Control 1 ml
CG0010 Anti-Cryptococcal Latex Reagent 3.5 ml
CG0020 Anti-Cryptococcal Latex Reagent 1.5 ml
DE0010 Detacher Enzyme 1.75 ml
EI0010 Enzyme Inhibitor (for DE) 6 ml
GB0020 Glycine Buffered Diluent with Albumin (GBDA, 10X Concentrate) 10 ml
N80010 Negative Control 1 ml
R20000 Anti-Globulin Control 2 ml